BrightGene Bio (China) Price History
688166 Stock | 30.92 1.21 4.07% |
Below is the normalized historical share price chart for BrightGene Bio Medical extending back to November 08, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of BrightGene Bio stands at 30.92, as last reported on the 28th of January, with the highest price reaching 31.17 and the lowest price hitting 29.99 during the day.
If you're considering investing in BrightGene Stock, it is important to understand the factors that can impact its price. At this point, BrightGene Bio is very steady. BrightGene Bio Medical secures Sharpe Ratio (or Efficiency) of 0.0268, which signifies that the company had a 0.0268 % return per unit of risk over the last 3 months. We have found twenty-three technical indicators for BrightGene Bio Medical, which you can use to evaluate the volatility of the firm. Please confirm BrightGene Bio's Risk Adjusted Performance of 0.0013, standard deviation of 3.49, and Mean Deviation of 2.35 to double-check if the risk estimate we provide is consistent with the expected return of 0.0935%.
The current year's Other Stockholder Equity is expected to grow to about 21.5 M, whereas Total Stockholder Equity is forecasted to decline to about 1.4 B. . BrightGene Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 30.7579 | 50 Day MA 31.0172 | Beta 0.386 |
BrightGene |
Sharpe Ratio = 0.0268
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | 688166 | Huge Risk |
Negative Returns |
Estimated Market Risk
3.48 actual daily | 31 69% of assets are more volatile |
Expected Return
0.09 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average BrightGene Bio is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BrightGene Bio by adding it to a well-diversified portfolio.
Price Book 5.553 | Enterprise Value Ebitda 70.2095 | Price Sales 10.522 | Shares Float 259.2 M | Wall Street Target Price 44.21 |
BrightGene Bio Stock Price History Chart
There are several ways to analyze BrightGene Stock price data. The simplest method is using a basic BrightGene candlestick price chart, which shows BrightGene Bio price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | November 13, 2024 | 35.93 |
Lowest Price | January 21, 2025 | 28.77 |
BrightGene Bio January 28, 2025 Stock Price Synopsis
Various analyses of BrightGene Bio's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell BrightGene Stock. It can be used to describe the percentage change in the price of BrightGene Bio from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of BrightGene Stock.BrightGene Bio Price Daily Balance Of Power | 1.03 | |
BrightGene Bio Price Action Indicator | 0.95 | |
BrightGene Bio Price Rate Of Daily Change | 1.04 | |
BrightGene Bio Accumulation Distribution | 381,995 |
BrightGene Bio January 28, 2025 Stock Price Analysis
BrightGene Stock Price History Data
The price series of BrightGene Bio for the period between Wed, Oct 30, 2024 and Tue, Jan 28, 2025 has a statistical range of 7.16 with a coefficient of variation of 5.38. The prices are distributed with arithmetic mean of 31.17. The median price for the last 90 days is 30.92. The company issued dividends on 2024-07-04.Open | High | Low | Close | Volume | ||
01/27/2025 | 29.99 | 31.17 | 29.99 | 30.92 | 10,090,502 | |
01/24/2025 | 29.68 | 30.07 | 29.26 | 29.71 | 8,002,388 | |
01/23/2025 | 30.00 | 30.87 | 29.64 | 29.70 | 7,985,220 | |
01/22/2025 | 28.60 | 31.50 | 28.46 | 30.21 | 14,156,165 | |
01/21/2025 | 29.20 | 29.20 | 28.51 | 28.77 | 4,943,949 | |
01/20/2025 | 29.90 | 30.11 | 28.55 | 29.05 | 7,403,096 | |
01/17/2025 | 29.89 | 30.24 | 29.61 | 29.68 | 4,456,301 | |
01/16/2025 | 29.50 | 30.10 | 29.30 | 30.10 | 5,389,062 | |
01/15/2025 | 29.65 | 29.91 | 29.32 | 29.38 | 4,292,706 | |
01/14/2025 | 28.87 | 29.68 | 28.72 | 29.55 | 6,679,561 | |
01/13/2025 | 28.82 | 29.20 | 28.45 | 28.87 | 3,618,597 | |
01/10/2025 | 29.17 | 29.70 | 29.01 | 29.01 | 3,017,217 | |
01/09/2025 | 29.70 | 29.70 | 29.11 | 29.31 | 3,126,807 | |
01/08/2025 | 29.69 | 29.95 | 28.65 | 29.55 | 5,960,414 | |
01/07/2025 | 30.30 | 30.30 | 29.07 | 29.56 | 7,365,945 | |
01/06/2025 | 30.50 | 31.20 | 30.11 | 30.20 | 8,666,442 | |
01/03/2025 | 29.71 | 30.63 | 29.50 | 29.66 | 6,684,980 | |
01/02/2025 | 30.02 | 30.50 | 29.52 | 29.75 | 5,522,563 | |
12/31/2024 | 31.03 | 31.08 | 30.20 | 30.20 | 6,115,861 | |
12/30/2024 | 31.70 | 32.20 | 30.90 | 30.99 | 5,970,410 | |
12/27/2024 | 31.77 | 32.47 | 31.51 | 31.70 | 6,879,936 | |
12/26/2024 | 30.18 | 31.94 | 30.02 | 31.85 | 11,855,498 | |
12/25/2024 | 30.20 | 30.30 | 29.55 | 30.14 | 5,749,693 | |
12/24/2024 | 30.32 | 30.50 | 29.95 | 30.14 | 5,564,573 | |
12/23/2024 | 31.45 | 31.55 | 30.06 | 30.28 | 8,398,700 | |
12/20/2024 | 32.32 | 32.32 | 31.21 | 31.39 | 7,479,374 | |
12/19/2024 | 31.65 | 32.39 | 31.65 | 32.03 | 5,604,043 | |
12/18/2024 | 33.35 | 33.73 | 31.71 | 32.01 | 9,475,636 | |
12/17/2024 | 33.50 | 33.93 | 33.16 | 33.23 | 8,517,926 | |
12/16/2024 | 32.87 | 34.56 | 32.62 | 33.60 | 13,011,167 | |
12/13/2024 | 33.22 | 33.48 | 32.13 | 33.20 | 12,244,865 | |
12/12/2024 | 31.59 | 34.06 | 31.01 | 33.80 | 16,539,668 | |
12/11/2024 | 32.19 | 32.25 | 31.05 | 31.36 | 8,626,275 | |
12/10/2024 | 32.78 | 32.99 | 32.00 | 32.30 | 9,229,067 | |
12/09/2024 | 32.83 | 33.14 | 31.61 | 32.00 | 8,096,318 | |
12/06/2024 | 32.60 | 32.82 | 31.75 | 32.79 | 9,146,273 | |
12/05/2024 | 33.20 | 33.25 | 32.13 | 32.59 | 7,211,726 | |
12/04/2024 | 32.90 | 33.82 | 32.60 | 33.12 | 10,803,650 | |
12/03/2024 | 32.27 | 32.76 | 31.72 | 32.76 | 9,554,165 | |
12/02/2024 | 31.80 | 32.55 | 31.52 | 32.35 | 9,964,512 | |
11/29/2024 | 31.39 | 32.35 | 31.08 | 31.96 | 9,138,894 | |
11/28/2024 | 32.30 | 32.30 | 31.30 | 31.60 | 6,503,778 | |
11/27/2024 | 31.00 | 32.17 | 30.71 | 32.00 | 11,290,591 | |
11/26/2024 | 31.31 | 31.90 | 30.87 | 30.89 | 6,296,610 | |
11/25/2024 | 30.35 | 31.65 | 30.27 | 31.65 | 9,956,562 | |
11/22/2024 | 32.20 | 32.80 | 30.32 | 30.35 | 10,648,088 | |
11/21/2024 | 32.16 | 32.48 | 31.30 | 31.90 | 8,832,830 | |
11/20/2024 | 31.51 | 32.70 | 31.40 | 32.15 | 12,473,017 | |
11/19/2024 | 30.00 | 32.40 | 30.00 | 31.65 | 15,371,968 | |
11/18/2024 | 31.07 | 31.40 | 29.62 | 29.90 | 14,102,525 | |
11/15/2024 | 33.10 | 33.79 | 31.10 | 31.22 | 17,912,120 | |
11/14/2024 | 37.11 | 37.40 | 33.30 | 33.56 | 16,989,259 | |
11/13/2024 | 35.39 | 36.15 | 33.90 | 35.93 | 18,381,809 | |
11/12/2024 | 35.00 | 36.99 | 35.00 | 35.56 | 26,053,755 | |
11/11/2024 | 32.06 | 36.26 | 32.06 | 35.56 | 31,054,588 | |
11/08/2024 | 31.03 | 31.46 | 30.40 | 30.59 | 13,442,074 | |
11/07/2024 | 29.62 | 30.75 | 29.55 | 30.66 | 12,435,919 | |
11/06/2024 | 30.18 | 30.74 | 29.02 | 29.75 | 11,702,266 | |
11/05/2024 | 29.00 | 30.03 | 28.70 | 30.03 | 12,337,340 | |
11/04/2024 | 28.94 | 29.60 | 28.88 | 29.22 | 6,920,671 | |
11/01/2024 | 30.00 | 30.80 | 28.68 | 28.79 | 13,846,231 |
About BrightGene Bio Stock history
BrightGene Bio investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for BrightGene is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in BrightGene Bio Medical will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing BrightGene Bio stock prices may prove useful in developing a viable investing in BrightGene Bio
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 485.8 M | 340.7 M | |
Net Income Applicable To Common Shares | 275.6 M | 141.5 M |
BrightGene Bio Quarterly Net Working Capital |
|
BrightGene Bio Stock Technical Analysis
BrightGene Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
All Next | Launch Module |
BrightGene Bio Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for BrightGene Bio's price direction in advance. Along with the technical and fundamental analysis of BrightGene Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of BrightGene to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0013 | |||
Jensen Alpha | (0.13) | |||
Total Risk Alpha | (0.26) | |||
Treynor Ratio | (0.02) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for BrightGene Stock analysis
When running BrightGene Bio's price analysis, check to measure BrightGene Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BrightGene Bio is operating at the current time. Most of BrightGene Bio's value examination focuses on studying past and present price action to predict the probability of BrightGene Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BrightGene Bio's price. Additionally, you may evaluate how the addition of BrightGene Bio to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |